Citations

1. Fisher RI, et al. (2005). Non-Hodgkin's lymphomas. In VT DeVita Jr et al., eds., Cancer: Principles and Practice of Oncology, 7th ed., pp. 1957–1997. Philadelphia: Lippincott Williams and Williams.

2. American Cancer Society (2005). Cancer Facts and Figures 2005, pp. 1–21. Atlanta: American Cancer Society. Also available online: http://www.cancer.org/downloads/STT/CAFF2005f4PWSecured.pdf.

3. Evans LS, Hancock BW (2003). Non-Hodgkin lymphoma. Lancet, 362(9378): 139–146.

4. Ardeshna KM, et al. (2003). Long-term effect of a watch and wait policy versus immediate systemic treatment for asymptomatic advanced-stage non-Hodgkin lymphoma: A randomised controlled trial. Lancet, 362(9383): 516–522.

5. Coiffier B, et al. (2002). CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. New England Journal of Medicine, 346(4): 235–242.

6. Milpied N, et al. (2004). Initial treatment of aggressive lymphoma with high-dose chemotherapy and autologous stem-cell support. New England Journal of Medicine, 350(13): 1287–1295.

Other Works Consulted

• American Joint Committee on Cancer (2002). Lymphoid neoplasms. AJCC Cancer Staging Manual, 6th ed., pp. 393–406. New York: Springer-Verlag.

• Foon KA, Fisher RI (2006). The non-Hodgkin lymphomas. In MA Lichtman et al., eds., Williams Hematology, 7th ed., pp. 1407–1459. New York: McGraw-Hill.

• McCune SL, et al. (2001). Monoclonal antibody therapy in the treatment of non-Hodgkin lymphoma. JAMA, 286(10): 1149–1152.